Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02116946 · ClinicalTrials.gov registry record · Phase 2
Plasma Injections Plus Exercise for Patellar Tendinopathy
A Phase 2 study, sponsored by University of British Columbia.
- Terminated
- Registry status
- Phase 2
- Development phase
- 64
- Enrollment target
NCT02116946 is a Phase 2 study that was terminated before completion, run by University of British Columbia. The registered enrollment target is 64 participants.
The verdict
NCT02116946, a Phase 2 study, was terminated before completion, sponsored by University of British Columbia.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 64 participants
- Enrollment target
Study Summary
This is a randomized controlled clinical trial to investigate the effectiveness, safety and tolerability of platelet-rich plasma (PRP) injections for treatment of patellar tendinopathy in adults 18-50 years of age. Subjects will be randomly assigned to three parallel treatment groups: 1. Leukocyte-rich PRP injection + exercise 2. Leukocyte-poor PRP injection + exercise 3. Saline injection + exercise (control) Primary endpoints are (1) the number (rate) and severity of adverse events as reported by both patients and study physicians during the first 12 weeks after initiation of treatment, (2) patient-rated tolerability of treatment; (3) the change in function (VISA score) and treatment success (global improvement scale) over six months of a post-injection exercise protocol.
Interventions
- BIOLOGICAL Platelet Rich Plasma (PRP)
- OTHER Saline + exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02116946
The ClinicalTrials.gov registry entry for NCT02116946 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of British Columbia, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelet Rich Plasma (PRP) is the first listed.
NCT02116946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02116946 about?
NCT02116946 is a clinical study titled "Plasma Injections Plus Exercise for Patellar Tendinopathy". This is a randomized controlled clinical trial to investigate the effectiveness, safety and tolerability of platelet-rich plasma (PRP) injections for treatment of patellar tendinopathy in adults 18-50 years of age. Subjects will be randomly assigned to three parallel treatment groups: 1. Leukocyte-...
What is the current status of trial NCT02116946?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2014-03. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02116946?
The interventions under investigation include: Platelet Rich Plasma (PRP) (BIOLOGICAL), Saline + exercise (OTHER).
Who is sponsoring clinical trial NCT02116946?
This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.